Jipmer enrolls first infant in NeoSep1 international clinical trial in fight against neonatal sepsis
Jipmer becomes the first Indian center to enroll an infant in the NeoSep1 trial, targeting neonatal sepsis and antimicrobial resistance.
India is participating in the NeoSep1 clinical trial, which aims to improve treatment for drug-resistant newborn sepsis using ...
Here are the latest guidelines on where fireworks are allowed in and around the Austin area.
Robert Welsh on MSN
The TikTok makeup haul that separates the genuine finds from the algorithm-driven garbage
TikTok creates purchase urgency faster than any review process can keep up with — and the only honest way to find out whether ...
Clariyon’s artificial intelligence (AI)-powered sepsis care agent has shown potential in improving a physician’s ability to ...
India has enrolled its first newborn in the global NeoSep1 trial at JIPMER, Puducherry. The study will test antibiotic ...
Researchers found that LLMs can perform accurate abstractions for complex quality measures, such as the SEP-1 measure for ...
The Global Antibiotic Research and Development Partnership (GARDP) said yesterday that an international clinical trial ...
A flu outbreak at Joint Base San Antonio Lackland Air Force Base has risen to 275 confirmed cases, up from 222 earlier in the ...
Flosonics Medical received the Paul and Debra Walker Award, part of the Sepsis Research and Innovation Challenge at the Unite for Sepsis Symposium presented by Sepsis Alliance in Washington, D.C. on ...
Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be harmed? She writes the weekly AI Prognosis newsletter. Follow her on Threads, Mastodon, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results